Trupanion, Inc.

Trupanion, Inc. (TRUP) Market Cap

Trupanion, Inc. has a market capitalization of $959.7M.

Price: $22.00

0.25 (1.15%)

Market Cap: 959.65M

NASDAQ · time unavailable

CEO: Margaret Rosemary Maria Tooth

Sector: Financial Services

Industry: Insurance - Specialty

IPO Date: 2014-07-18

Website: https://www.trupanion.com

Trupanion, Inc. (TRUP) - Company Information

Market Cap: 959.65M|Sector: Financial Services

Company Profile

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.

Analyst Sentiment

79%
Strong Buy

From 6 Active Polls

1Y Forecast: $38.00

▲ +72.7% Potential Upside

Consensus Target Metrics

Low Bound

$34

Median

$35

High Bound

$45

Average

$38

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$38.00
▲ +72.73% Upside
Low Target
$34.00
55% Risk
Median Target
$35.00
59% Mid
High Target
$45.00
105% Max
Consensus
Buy
9 / 15 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)9601,1141,5801,8642,3731,5942,0321,7731,206
Enterprise Value ($M)9161,0701,5541,8242,3651,5572,0011,7641,211
Price to Earnings Ratio (P/E)37.1057.0870.1679.3663.02-268.76306.77311.05-51.45
Price/Earnings-to-Growth Ratio (PEG)29.8925.9221.0018.61-194.20101.9777.37-18.15
Price to Sales Ratio (P/S)0.652.904.195.086.714.666.025.413.83
Price to Book Ratio (P/B)2.422.824.125.066.684.786.295.543.94
Price to Free Cash Flow Ratio (P/FCF)12.7881.0562.3577.89196.94113.5893.03132.49303.42
Enterprise Value to Sales (EV/Sales)2.794.124.976.694.555.935.393.85
Enterprise Value to EBITDA (EV/EBITDA)15.9092.75107.90135.72130.00280.11221.19182.56569.86
Debt to Equity Ratio-0.770.280.290.310.320.390.400.400.42

TRUP Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$22.00
Intrinsic Value$22.02
Market Alignment
Undervalued by 0.1%relative to calculated intrinsic value
9.00%
Exp: 4%4%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$0.14B
Perpetuity TV Value$2.69B
Discounted TV (PV)$1.14B
TV Weighting %60.8%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 TRUPANION INC (TRUP) — Investment Overview

🧩 Business Model Overview

Trupanion sells pet insurance primarily as a direct-to-consumer product, underwriting policies and paying covered veterinary claims. The economic flow is straightforward: premiums collected from policyholders fund claim payments and operating costs, while underwriting profitability depends on maintaining disciplined pricing and reserving while managing claim frequency and severity.

A meaningful portion of the customer experience is driven by claims administration and customer service—areas that influence renewal behavior, customer retention, and loss adjustment efficiency.

💰 Revenue Streams & Monetisation Model

Revenue is dominated by recurring premium revenue, which is recognized over the coverage period. Unlike transactional models, pet insurance has recurring economics: customers retain coverage by renewing policies, and future revenue is driven by both new policy acquisition and existing policy retention.

Monetisation hinges on the spread between:

  • Earned premiums
  • minus incurred claims and claim adjustment expenses
  • minus operating costs (distribution, customer service, admin, technology)

The primary margin driver is the underwriting margin, which depends on pricing adequacy versus expected losses, reserve quality, and operating leverage as policy counts scale. Because claims can be volatile, profitability sensitivity is higher to assumptions around utilization and veterinary cost inflation than in more stable consumer subscription categories.

🧠 Competitive Advantages & Market Positioning

Trupanion’s core moat is best framed as switching costs created by coverage history and underwriting mechanics, reinforced by operational execution in claims handling.

  • High switching costs (coverage continuity): once a pet is enrolled, the value of maintaining coverage increases as the policyholder builds coverage history, experiences the claim process, and gains familiarity with claim administration. Switching to a new insurer often implies underwriting limitations, waiting periods, and potential treatment of pre-existing conditions—factors that reduce churn.
  • Operational moat (claims and servicing capabilities): insurers compete not only on pricing, but also on claim servicing efficiency, customer satisfaction, and accuracy of claim review. These factors influence retention and the cost-to-administer each claim.
  • Reinsurer and risk management discipline: underwriting performance reflects pricing, reserving, and reinsurance strategy discipline. Strong actuarial controls reduce the probability that loss creep overwhelms premium adequacy.

Competitive benchmarking (industry focus and peers):

  • Healthy Paws (direct-to-consumer pet insurance, strong digital acquisition): competes on consumer experience and product breadth; Trupanion differentiates through underwriting/servicing execution and customer retention dynamics.
  • Fetch / Paw Protect (Chewy ecosystem / distribution partners): emphasizes distribution scale through partnerships; Trupanion competes by focusing on direct policyholder experience and claims servicing consistency rather than relying primarily on partner distribution.
  • Nationwide (multiline insurer offering pet coverage): leverages brand and distribution channels; Trupanion’s position is more focused on pure-play pet insurance economics and risk discipline.

Overall, Trupanion’s positioning is less about broad brand-driven cross-selling and more about retention economics stemming from switching costs and underwriting/claims operations.

🚀 Multi-Year Growth Drivers

Across a 5–10 year horizon, growth prospects are tied to secular adoption and cost inflation rather than cyclical demand:

  • Rising veterinary spend: advances in diagnostics, therapeutics, and treatment options increase the probability of higher-cost claims, supporting the value proposition of insurance.
  • Low-to-moderate penetration of pet insurance: expansion is driven by converting more pet owners into insured owners and increasing policy density over time.
  • Category education and digital acquisition: improved online quoting, underwriting transparency, and consumer-friendly claims workflows support customer acquisition efficiency.
  • Geographic expansion and distribution depth: building scale in core regions can support underwriting stability and operational leverage.

The TAM expands as both (1) pet population and (2) the share of pets insured increase, while underwriting discipline determines whether that growth translates into sustainable profitability.

⚠ Risk Factors to Monitor

  • Adverse selection and pricing pressure: if acquisition concentrates in segments with higher than expected claim propensity, loss ratios can deteriorate even with premium growth.
  • Veterinary cost inflation vs. actuarial assumptions: if medical cost growth outpaces pricing updates, profitability can be pressured.
  • Reserve adequacy: reserve-setting errors can materially affect incurred loss results and underwriting margins.
  • Regulatory and solvency requirements: insurance regulation, rate setting constraints, and capital adequacy standards can limit operational flexibility.
  • Competitive intensity: competitors can compress premiums to gain share; maintaining underwriting discipline is critical to prevent a race-to-the-bottom.

📊 Valuation & Market View

Markets typically value pet insurers through insurance operating metrics rather than traditional high-growth software multiples. The key valuation drivers include:

  • Growth in earned premiums (or policy counts) balanced against underwriting margin
  • Loss ratio / combined ratio profile (claims severity and frequency vs. pricing adequacy)
  • Retention and net revenue durability (a proxy for switching costs and product-market fit)
  • Capital efficiency (ability to scale underwriting while meeting regulatory capital needs)

In practice, valuation tends to move with changes in perceived underwriting quality, confidence in reserving, and the sustainability of premium adequacy under competitive and medical cost pressures.

🔍 Investment Takeaway

Trupanion’s long-term thesis rests on switching-cost-driven retention and operational discipline in claims and underwriting. While the category is structurally supported by rising veterinary utilization and low penetration, sustained value creation depends on maintaining pricing adequacy, reserving accuracy, and loss ratio control as the company scales.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for TRUP.

zacks.com2026-05-27

Is the Options Market Predicting a Spike in Trupanion Stock?

Investors need to pay close attention to TRUP stock based on the movements in the options market lately.

globenewswire.com2026-05-26

Lacy Pushes Trupanion Past $4 Billion in Paid Claims, Helping More than 3.9 Million Pets Receive Care

After taking 20 years to reach its first $1 billion in paid claims, Trupanion surpassed $4 billion just 18 months after crossing $3 billion, highlighting the growing role of high-quality pet insurance in reducing barriers to care. SEATTLE, May 26, 2026 (GLOBE NEWSWIRE) -- When Lacy, a three-year-old Goldendoodle from Illinois, recently received medication to help manage her allergies, it meant more than relief from a chronic condition—it meant her family could focus on her comfort rather than the bill.

zacks.com2026-05-19

5 Stocks to Watch From Prospering Accident & Health Insurance Industry

Accident and Health Insurance stocks like AFL, UNM, GL, TRUP and EIG are set to gain from rising underwriting exposure and accelerated digitalization. However, pricing pressure is a concern given rising medical costs and inflation.

seekingalpha.com2026-05-01

Trupanion, Inc. (TRUP) Q1 2026 Earnings Call Transcript

Trupanion, Inc. (TRUP) Q1 2026 Earnings Call Transcript

zacks.com2026-04-30

Trupanion (TRUP) Reports Q1 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Trupanion (TRUP) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

zacks.com2026-04-30

Trupanion (TRUP) Q1 Earnings and Revenues Beat Estimates

Trupanion (TRUP) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to a loss of $0.03 per share a year ago.

globenewswire.com2026-04-30

Trupanion Reports First Quarter 2026 Results

SEATTLE, April 30, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2026.  “The gap between the cost of veterinary care and what pet parents can reasonably plan for continues to widen,” said Margi Tooth, Chief Executive Officer and President of Trupanion.

zacks.com2026-04-28

Unum (UNM) Beats Q1 Earnings and Revenue Estimates

Unum (UNM) came out with quarterly earnings of $2.14 per share, beating the Zacks Consensus Estimate of $2.07 per share. This compares to earnings of $2.04 per share a year ago.

globenewswire.com2026-04-27

Trupanion Publishes 2025 Annual Letter to Shareholders

SEATTLE, April 27, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, has published its 2025 annual shareholder letter from CEO and President, Margi Tooth. The letter is now available on the Company's Investor Relations website here.

zacks.com2026-04-23

Trupanion (TRUP) Earnings Expected to Grow: Should You Buy?

Trupanion (TRUP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

globenewswire.com2026-04-16

Trupanion Announces First Quarter 2026 Earnings Release and Conference Call

SEATTLE, April 16, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2026 first quarter after the market closes on Thursday, April 30, 2026. The company will host a conference call that day beginning shortly after 1:30 p.m.

gurufocus.com2026-04-14

A Look at Trupanion Inc (TRUP) After 3.8% Gain -- GF Value $40.73 vs Price $26.26

On April 14, 2026, Trupanion Inc (TRUP) shares rose 3.8% to a current price of $26.26. The stock has experienced significant volatility over the past year, trad

defenseworld.net2026-04-05

JPMorgan Chase & Co. Lowers Stake in Trupanion, Inc. $TRUP

JPMorgan Chase and Co. lessened its position in Trupanion, Inc. (NASDAQ: TRUP) by 52.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 77,649 shares of the financial services provider's stock after selling 84,132 shares during the

fool.com2026-03-24

Trupanion's CFO Just Sold His Last Share. The Filing Explains Why

2,837 shares sold on Feb. 27, 2026 at a weighted average price of $26.46 per share, totaling approximately ~$75,000 in transaction value. This sale represented 100.00% of Qureshi's direct holdings, reducing direct and indirect ownership of common stock to zero after the transaction.

seekingalpha.com2026-03-11

Trupanion: Pet Insurer Hits Key Milestone (Rating Upgrade)

Trupanion is upgraded to Buy after achieving its first GAAP profit and demonstrating improved financial resilience. Gross margins rose from 12% to 16% (2023–2025), with operating leverage and scalable digital operations supporting sustainable free cash flow growth. TRUP targets 14% subscription revenue growth in 2026, with U.S. pet insurance penetration under 4% and significant runway for expansion.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"TRUP reported Q1 2026 revenue of $384.0M and net income of $4.9M (EPS $0.11). On a YoY basis, revenue rose +12.2% (vs. $342.0M in Q1 2025) and net income improved from a loss of -$1.48M to +$4.88M. QoQ, revenue increased +1.9% (vs. Q4 2025) while net income declined -13.3% (from $5.63M in Q4 2025). Profitability improved markedly YoY: net margin was 1.27% in Q1 2026 versus -0.43% in Q1 2025, indicating a clear turnaround despite still-thin margins. Gross margin was unusually high in Q1 2026 (89.3%) compared with Q1 2025 (14.9%), though the reported cost structure appears volatile across quarters, so the direction is more important than the absolute level. Cash flow quality appears solid relative to earnings: operating cash flow was $14.6M and free cash flow was $13.7M, turning positive despite net income softness QoQ. Balance sheet leverage looks contained with net cash (net debt -$44.1M) and sizable equity ($394.8M) that is broadly stable QoQ. Shareholder returns are currently muted: the stock is down -17.5% over 1Y, with no dividend or repurchases reported in this dataset. Analyst targets suggest potential upside versus the $28.2 share price, but valuation multiples remain high given the quarter’s modest profitability."

Revenue Growth

Positive

YoY revenue growth was +12.2% in Q1 2026 (vs Q1 2025). QoQ revenue was up +1.9% (vs Q4 2025), indicating steady but moderate sequential momentum.

Profitability

Fair

Net income improved YoY from -$1.48M to +$4.88M, but QoQ net income fell -13.3%. Margins are still thin (net margin 1.27%); gross margin shows extreme quarter-to-quarter volatility, so results should be interpreted cautiously.

Cash Flow Quality

Neutral

Operating cash flow was $14.6M and free cash flow $13.7M in Q1 2026, supporting earnings quality despite the QoQ decline in net income. No dividends were paid; buybacks were reported as none.

Leverage & Balance Sheet

Positive

Net debt remains negative (net cash position of ~$44M). Total assets rose slightly QoQ to $921.6M and equity increased modestly, suggesting reasonable balance-sheet resilience.

Shareholder Returns

Neutral

Market momentum is weak: 1Y price change is -17.5% with no dividend yield reported and no buybacks indicated in the cash flow data.

Analyst Sentiment & Valuation

Fair

Consensus price target ($38) is above the current ~$28.2 price, implying potential upside. However, valuation appears stretched relative to current earnings (high price/earnings in the ratio set).

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

TRUP delivered strong Q1 2026 momentum: revenue rose 12% YoY to $384m and adjusted operating income increased 29% YoY to $40.2m, with subscription AOI up 28% to $38.4m and subscription margin expanding ~130 bps to 14.2%. The value proposition improved to 70.8% despite $3.1m adverse development (~120 bps). Operating leverage came from lower fixed costs (5.8% vs 6.2%) and stable variable expenses (9.1%). Growth is being supported by AI/claims automation (automation rate 62% vs 56%) and a late-Q1 rollout of deductible/coinsurance flexibility that improved web conversion without materially shifting pet parents’ selected coverage levels. Guidance remains intact: FY2026 total revenue $1.556b–$1.581b and AOI $173m–$187m (19% YoY at midpoint). In Q&A, analysts probed hospital software footprint vs pet conversion and the new product’s pricing logic; management reiterated that same-store sales should recover as territory execution deepens, and AOI remains the primary investment-return yardstick.

AI IconGrowth Catalysts

  • Expanded strategic rollout of increased flexibility to the core Trupanion product (Canada first; now in a handful of U.S. states) with improved web conversion versus prior periods and coverage selection trending toward core-like levels
  • Reorganization of growth under a single leader to unify lead generation through conversion and retention to support the new strategic plan execution
  • Claims automation and improved member experience investments; AI-driven automation rate increased to 62% from 56% last year
  • Brand-new digital-first product planned for later in 2026 to target Millennials/Gen Z and address higher entry price points through online experience and more optionality

Business Development

    AI IconFinancial Highlights

    • Adjusted operating income (AOI): $40.2m in Q1 2026, +29% YoY; subscription AOI $38.4m (+28% YoY) driving 96% of total AOI
    • Total revenue: $384m, +12% YoY; subscription revenue $269.5m, +16% YoY and above high end of expectations
    • Subscription pets: 1.106m as of Mar 31, +5% YoY (includes ~64,000 pets in Europe); added ~64,700 pets in Q1
    • Monthly average revenue per pet: $85.79, +11% YoY
    • Retention (trailing twelve months): 98.35%, up vs 98.28% prior-year Q1
    • Value proposition (cost of paying vet invoices): 70.8% vs 71.8% prior-year Q1; adverse development from prior periods: $3.1m (~120 bps of subscription revenue)
    • Subscription variable expenses: 9.1% of subscription revenue (in line with prior year); fixed expenses: 5.8% of revenue (down from 6.2%); total fixed+variable spending: 14.9% of revenue vs 15.3% prior year
    • Subscription adjusted operating margin: 14.2% (highest Q1 in history) up from 12.9% prior year (~130 bps of margin expansion)
    • Other segment deceleration: other business revenue $114.6m (+5% YoY); no longer enrolling new pets in most U.S. states for its largest partner; other segment AOI $1.8m (1.6% margin)
    • Net income: $4.9m, or $0.11 per basic/diluted share vs net loss $1.5m, or $0.03 per basic/diluted share in prior-year quarter
    • Cash flow: operating cash flow $14.6m vs $16.0m prior year; free cash flow $13.7m ~in line with prior year; capex $0.8m vs $1.9m prior-year Q1

    AI IconCapital Funding

    • Cash and short-term investments: $383.7m at quarter end
    • Total debt: $109.3m, down $19.5m vs Q1 2025; management cited paying down debt as part of financial investments
    • No buyback amounts or explicit share repurchase authorization mentioned in the transcript

    AI IconStrategy & Ops

    • Early rollout of core-product flexibility (deductible and coinsurance changes) began very late Q1; initially available in Canada and expanded to a handful of U.S. states with intent to expand broadly through the year
    • New product concept: digital-first, all online, intended for new pet-parent audiences; created to leverage Trupanion brand reputation, direct payment, and pet acquisition investments; expected to launch later in 2026 (timing updates in next few months)
    • Automation: automation rate increased to 62% in the quarter from 56% last year, aiming to lower claims processing cost and improve member experience
    • Segment/channel operations: other segment expected growth to decelerate due to reduced enrollment (largest partner no longer enrolling new pets in most U.S. states)

    AI IconMarket Outlook

    • Full-year 2026: total revenue $1.556b to $1.581b; subscription revenue $1.119b to $1.135b (about 14% YoY growth at midpoint)
    • Full-year 2026 AOI: $173m to $187m (about 19% YoY growth at midpoint)
    • Q2 2026 guidance: total revenue $386m to $392m; subscription revenue $274m to $277m (about 14% YoY growth at midpoint)
    • Q2 2026 AOI: $40m to $43m (about 19% YoY growth at midpoint)
    • Guidance currency sensitivity: revenue projections assume 73% U.S./Canadian conversion rate for Q2 and full-year

    AI IconRisks & Headwinds

    • Hospital/territory partner productivity deceleration: management noted same-store sales change down while hospital/software footprint widened, implying slower gross add pet count conversion from new software deployments
    • Other segment growth deceleration risk: no longer enrolling new pets in most U.S. states for its largest partner in the segment
    • Pet lead volume and vet industry softness: analysts asked about macro adoption; management referenced downturn in vet visits and wellness visits and flattish lead volume in Q1 (with uptick in Q2)
    • Cost of veterinary support inflation / access constraints: management highlighted rising veterinary support costs limiting access to care for uninsured pets (benefit opportunity but indicates ongoing cost pressure dynamics)
    • Adverse prior-period development: $3.1m adverse development (~120 bps of subscription revenue) impacted Q1 value proposition

    Q&A: Analyst Interest

    • Hospital software growth vs pet count: Management explained that software (hospital footprint) expanded faster than same-store sales, driving fewer new pets per hospital. They attributed it to territory partners going wide then deep, expecting same-store sales and active hospitals to build over time, correlating with gross adds.
    • New product economics and mechanics: Management described the North America plan as expanding the core product’s coverage levels after 25 years using higher deductibles and varying coinsurance to widen price points. They said early rollout in late Q1 showed little shift toward lower options, indicating more choice without materially altering selection.
    • IRR metric removal and investment confidence: Management said blended IRR became less relevant due to scaling complexity and multiple products/geographies, and competitive sensitivity. They emphasized AOI as the clearer metric and cited sequentially improved IRR performance this quarter, while maintaining internal guardrails.

    Sentiment: POSITIVE

    Note: This summary was synthesized by AI from the TRUP Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

    📋 Official Regulatory 10-K / 10-Q SEC Filings

    Direct authenticated documentation links to audited SEC database reports for TRUP.

    SEC EDGAR Live Feed
    Loading financial data and tables...
    📁

    SEC Filings (TRUP)

    © 2026 Stock Market Info — Trupanion, Inc. (TRUP) Financial Profile